Ratings Summary for ENBREL
Overall Patient opinion of ENBREL: 3.7 (satisfied)
(based on 534 reviews ) (updated May 6, 2025)Ratings by Age Group for ENBREL
Rating Scale from 1 (poor) to 5 (excellent)
| Patient Age Group | Number of Reviews | Average Rating |
|---|---|---|
| Pediatric (Under 18) | 18 | 3.6 |
| Age 18 to 24 | 24 | 4.1 |
| Age 25 to 34 | 72 | 4.1 |
| Age 35 to 44 | 129 | 3.8 |
| Age 45 to 54 | 150 | 3.6 |
| Age 55 to 64 | 111 | 3.5 |
| Age 65 to 74 | 20 | 4.1 |
| Age 75 and up | 3 | 4 |
Ratings by Sex for ENBREL
Rating Scale from 1 (poor) to 5 (excellent)
| Patient Sex | Number of Reviews | Average Rating |
|---|---|---|
| Male | 165 | 3.95151515151515 |
| Female | 362 | 3.67955801104972 |
| Not Specified | 7 | 3.14285714285714 |
Would you like to find reviews for ENBREL taken for a specific reason or resulting in a specific side effect?
Filter Results for ENBREL
FDA Drug Safety Information for ENBREL
Check here for Ask a Patient's Adverse Event Summary for ENBREL based on cases submitted to the FDA. Includes top reasons for taking, adverse events, and major outcomes reported.
ENBREL (ETANERCEPT): This medication is used alone or in combination with an immunosuppressant (such as methotrexate) to treat certain types of arthritis (such as rheumatoid, psoriatic, juvenile idiopathic, and ankylosing spondylitis). Some brands of this medication are also used to treat a skin condition called psoriasis. These conditions are caused by an overactive immune system (autoimmune disease). The immune system attacks the body's own healthy cells, causing inflammation in the joints and skin. Etanercept controls your body's defensive response by blocking the action of a certain natural substance (TNF) that is used by the immune system. Treatment decreases redness, itching and scaly patches in psoriasis as well as the pain, swelling and stiffness of joints in arthritis. This medication can stop the progression of disease and joint damage, resulting in improved daily functioning and quality of life. This medication treats but does not cure autoimmune diseases. Symptoms usually return within 1 month of stopping the medication. FDA Approval Date: (Sources: U.S. Centers for Medicare Services, FDA)